Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cranston, I.
Right arrow Articles by Amiel, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cranston, I.
Right arrow Articles by Amiel, S. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:2329-2366, 2001
© 2001 by the American Diabetes Association, Inc.

Changes in Regional Brain 18F-Fluorodeoxyglucose Uptake at Hypoglycemia in Type 1 Diabetic Men Associated With Hypoglycemia Unawareness and Counter-Regulatory Failure

Iain Cranston1, Laurence J. Reed2,3, Paul K. Marsden2, and Stephanie A. Amiel1

1 Department of Medicine, Guy’s, King’s and St. Thomas’ Medical School, King’s College, London, U.K.
2 Clinical PET Centre, Guy’s, King’s and St. Thomas’ Medical School, King’s College, London, U.K.
3 Brain Image Analysis Unit, Institute of Psychiatry, De Crespigny Park, King’s College, London, U.K.

We examined the effects of acute moderate hypoglycemia and the condition of hypoglycemia unawareness on regional brain uptake of the labeled glucose analog [18F]fluorodeoxyglucose (FDG) using positron emission tomography (PET). FDG-PET was performed in diabetic patients with (n = 6) and without (n = 7) hypoglycemia awareness. Each patient was studied at plasma glucose levels of 5 and 2.6 mmol/l, applied by glucose clamp techniques, in random order. Hypoglycemia-unaware patients were asymptomatic during hypoglycemia, with marked attenuation of their epinephrine responses (mean [± SD] peak of 0.77 ± 0.39 vs. 7.52 ± 2.9 nmol/l; P < 0.0003) and a reduced global brain FDG uptake ([mean ± SE] 2.592 ± 0.188 vs. 2.018 ± 0.174 at euglycemia; P = 0.027). Using statistical parametric mapping (SPM) to analyze images of FDG uptake, we identified a subthalamic brain region that exhibited significantly different behavior between the aware and unaware groups. In the aware group, there was little change in the normalized FDG uptake in this region in response to hypoglycemia ([mean ± SE] 0.654 ± 0.016 to 0.636 ± 0.013; NS); however, in the unaware group, the uptake in this region fell from 0.715 ± 0.015 to 0.623 ± 0.012 (P = 0.001). Our data were consistent with the human hypoglycemia sensor being anatomically located in this brain region, and demonstrated for the first time a change in its metabolic function associated with the failure to trigger a counter-regulatory response.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. M. Arbelaez, W. J. Powers, T. O. Videen, J. L. Price, and P. E. Cryer
Attenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition: A Mechanism for Hypoglycemia-Associated Autonomic Failure
Diabetes, February 1, 2008; 57(2): 470 - 475.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. T. Dunn, I. Cranston, P. K. Marsden, S. A. Amiel, and L. J. Reed
Attenuation of Amydgala and Frontal Cortical Responses to Low Blood Glucose Concentration in Asymptomatic Hypoglycemia in Type 1 Diabetes: A New Player in Hypoglycemia Unawareness?
Diabetes, November 1, 2007; 56(11): 2766 - 2773.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. W. Mastaitis, E. Wurmbach, H. Cheng, S. C. Sealfon, and C. V. Mobbs
Acute Induction of Gene Expression in Brain and Liver by Insulin-Induced Hypoglycemia
Diabetes, April 1, 2005; 54(4): 952 - 958.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
J. K. Young and J. C. McKenzie
GLUT2 Immunoreactivity in Gomori-positive Astrocytes of the Hypothalamus
J. Histochem. Cytochem., November 1, 2004; 52(11): 1519 - 1524.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. E. Cryer
Diverse Causes of Hypoglycemia-Associated Autonomic Failure in Diabetes
N. Engl. J. Med., May 27, 2004; 350(22): 2272 - 2279.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Teves, T. O. Videen, P. E. Cryer, and W. J. Powers
Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia
PNAS, April 20, 2004; 101(16): 6217 - 6221.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. C. McNay and R. S. Sherwin
Effect of Recurrent Hypoglycemia on Spatial Cognition and Cognitive Metabolism in Normal and Diabetic Rats
Diabetes, February 1, 2004; 53(2): 418 - 425.
[Abstract] [Full Text]


Home page
Diabetes CareHome page
P. E. Cryer, S. N. Davis, and H. Shamoon
Hypoglycemia in Diabetes
Diabetes Care, June 1, 2003; 26(6): 1902 - 1912.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.